Short Interest in Coloplast A/S (OTCMKTS:CLPBY) Expands By 27.7%

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) was the recipient of a significant growth in short interest in October. As of October 31st, there was short interest totalling 80,200 shares, a growth of 27.7% from the October 15th total of 62,800 shares. Based on an average daily volume of 120,000 shares, the days-to-cover ratio is presently 0.7 days.

Coloplast A/S Stock Up 2.7 %

CLPBY traded up $0.34 during trading on Friday, reaching $12.88. The company’s stock had a trading volume of 89,996 shares, compared to its average volume of 76,532. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.85 and a quick ratio of 0.56. The company’s fifty day moving average price is $13.14 and its 200-day moving average price is $12.85. Coloplast A/S has a 52-week low of $10.57 and a 52-week high of $14.34.

Coloplast A/S (OTCMKTS:CLPBYGet Free Report) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $0.08 earnings per share for the quarter. Coloplast A/S had a net margin of 18.69% and a return on equity of 31.17%. The business had revenue of $1.02 billion for the quarter. Research analysts forecast that Coloplast A/S will post 0.38 earnings per share for the current fiscal year.

Coloplast A/S Increases Dividend

The company also recently declared a dividend, which will be paid on Friday, December 20th. Stockholders of record on Monday, December 9th will be issued a dividend of $0.2435 per share. The ex-dividend date of this dividend is Monday, December 9th. This is an increase from Coloplast A/S’s previous dividend of $0.05. Coloplast A/S’s payout ratio is 27.27%.

Coloplast A/S Company Profile

(Get Free Report)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.

Read More

Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.